Validity of the ESC Risk Assessment in Idiopathic Pulmonary Arterial Hypertension in China

Código QR

Validity of the ESC Risk Assessment in Idiopathic Pulmonary Arterial Hypertension in China

Background: The 2015 European pulmonary hypertension (PH) guidelines recommend a risk stratification strategy for pulmonary arterial hypertension (PAH). We aimed to investigate the validation and potential prognostic information in Chinese patients.Methods: The risk assessment variables proposed by...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Su-Gang Gong, Wen-Hui Wu, Chao Li, Qin-Hua Zhao, Rong Jiang, Ci-Jun Luo, Hong-Ling Qiu, Jin-Ming Liu, Lan Wang, Rui Zhang
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	pulmonary arterial hypertension idiopathic pulmonary arterial hypertension risk assessment guideline prognosis Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/fad0d632f83042c09e218ee1d006ae2c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Pulmonary artery dissection in long standing idiopathic pulmonary arterial hypertension: A case report
por: Luis Regalado, BS, MSc, et al.
Publicado: (2022)

Predictive value of chest HRCT for survival in idiopathic pulmonary arterial hypertension
por: Aneta Kacprzak, et al.
Publicado: (2021)

Evidence base for specific pulmonary vasodilators in adults with congenital heart disease
por: Anton A. Shmalts, et al.
Publicado: (2021)

Clinical practice guidelines on the diagnosis and treatment of patients with arterial hypertension and chronic obstructive pulmonary disease
por: Irina E. Chazova, et al.
Publicado: (2020)

Prevalence of Micronutrient Deficiencies and Relationship with Clinical and Patient-Related Outcomes in Pulmonary Hypertension Types I and IV
por: Paulien Vinke, et al.
Publicado: (2021)

Upregulation of IRF9 Contributes to Pulmonary Artery Smooth Muscle Cell Proliferation During Pulmonary Arterial Hypertension
por: Yong-Jie Chen, et al.
Publicado: (2021)

Hipertensión pulmonar y embarazo
por: Valdés S,Gloria, et al.
Publicado: (2002)

Gene Mutation Annotation and Pedigree for Pulmonary Arterial Hypertension Patients in Han Chinese Patients
por: Mei-Tzu Wang, et al.
Publicado: (2021)

Construction of a Support Vector Machine–Based Classifier for Pulmonary Arterial Hypertension Patients
por: Zhenglu Shang, et al.
Publicado: (2021)

Pulmonary hypertension in patients with hemodynamically significant atherosclerotic lesion of a common carotid artery: new pathophysiological mechanisms of the disease
por: M. A. Markov, et al.
Publicado: (2020)

Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies
por: Tselios K, et al.
Publicado: (2016)

Prognostic impact of hypochromic erythrocytes in patients with pulmonary arterial hypertension
por: Panagiota Xanthouli, et al.
Publicado: (2021)

Pulmonary Hypertension in the Dog
por: Poser Helen, et al.
Publicado: (2016)

Specificity of the effect of double fractures of the rhythmogram on the daily variability of the sinus rhythm in patients with pulmonary and arterial hypertension
por: Alexander V. Sobolev, et al.
Publicado: (2021)

Pulmonary hypertension in left heart disease
por: Pratishtha Mehra, et al.
Publicado: (2018)

Therapy for Pulmonary Arterial Hypertension: Glance on Nitric Oxide Pathway
por: Abraham Tettey, et al.
Publicado: (2021)

Cambios agudos en la función auricular derecha post uso de iloprost inhalatorio en pacientes con hipertensión arterial pulmonar: estudio con técnicas de deformación de imagen
por: Kanacri,Andrés, et al.
Publicado: (2015)

The role of TGF-β or BMPR2 signaling pathway-related miRNA in pulmonary arterial hypertension and systemic sclerosis
por: Bei Xu, et al.
Publicado: (2021)

Niveles aumentados de estrés oxidativo se asocian a disfunción endotelial periférica y respuesta vascular pulmonar disminuida frente a vasodilatadores en pacientes con hipertensión pulmonar
por: Gabrielli,Luigi, et al.
Publicado: (2010)

A Feasibility Study on Using Single-Photon Emission Computed Tomography Pulmonary Perfusion/Ventilation Imaging for the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension and Patient Risk Assessment
por: Ma RZ, et al.
Publicado: (2021)

Exercise-Induced Pulmonary Hypertension: How to Define, Diagnose, and Treat At-Risk Patients
por: Brandon Shokoples, et al.
Publicado: (2021)

Traditional Herbal Medicine Discovery for the Treatment and Prevention of Pulmonary Arterial Hypertension
por: Zhifeng Xue, et al.
Publicado: (2021)

Role of the Purinergic P2Y2 Receptor in Pulmonary Hypertension
por: Mazen Shihan, et al.
Publicado: (2021)

Measurement of Pulmonary Artery Wave Reflection Before and After Mitral Valvuloplasty in Canine Patients With Pulmonary Hypertension Caused by Myxomatous Mitral Valve Disease
por: Tomohiko Yoshida, et al.
Publicado: (2021)

In vivo Pharmacokinetics and in vitro Release of Imatinib Mesylate-Loaded Liposomes for Pulmonary Delivery
por: Xu H, et al.
Publicado: (2021)

THE INFLUENCE OF CONCOMITANT CARDIOVASCULAR PATHOLOGY (ISCHEMIC HEART DISEASE AND ARTERIAL HYPERTENSION) ON THE CHANGES OF RIGHT VENTRICLE OF HEART IN MINERS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
por: O. Yu. Korotenko, et al.
Publicado: (2012)

Non-Invasive Risk Prediction Based on Right Ventricular Function in Patients with Pulmonary Arterial Hypertension
por: Vazhma Qaderi, et al.
Publicado: (2021)

Pulmonary arterial hypertension: achievements and realities of modern treatment, a look into the future
por: Tamila V. Martynyuk, et al.
Publicado: (2021)

Identification of ferroptosis-associated genes exhibiting altered expression in pulmonary arterial hypertension
por: Fan Zhang, et al.
Publicado: (2021)

Intratracheal instillation of ethyl pyruvate nanoparticles prevents the development of shunt-flow-induced pulmonary arterial hypertension in a rat model
por: Liu K, et al.
Publicado: (2016)

Fibrinolytic markers could be useful predictors of severity in patients with pulmonary arterial hypertension: a retrospective study
por: Makoto Shoji, et al.
Publicado: (2021)

Assessing the spectrum of pulmonary hypertension identified at an Egyptian expert referral center
por: Mostafa Elshazly, et al.
Publicado: (2021)

Prognostic implications of pulmonary wave reflection and reservoir pressure in patients with pulmonary hypertension
por: K. Wustmann, et al.
Publicado: (2021)

Angioplastía con balón para el tratamiento de la hipertensión arterial pulmonar por enfermedad tromboembólica crónica. Resultados hemodinámicos y clínicos inmediatos
por: Sepúlveda,Pablo, et al.
Publicado: (2019)

Epigenetic Regulation of Endothelial Dysfunction and Inflammation in Pulmonary Arterial Hypertension
por: Jaylen Hudson, et al.
Publicado: (2021)

Post-interventional Evaluation and Follow-Up in Children With Patent Ductus Arteriosus Complicated With Moderate to Severe Pulmonary Arterial Hypertension: A Retrospective Study
por: Xing Rong, et al.
Publicado: (2021)

CYP2J2 and EETs protect against pulmonary arterial hypertension with lung ischemia–reperfusion injury in vivo and in vitro
por: Yun Ding, et al.
Publicado: (2021)

Single‐Beat Estimation of Right Ventricular Contractility and Its Coupling to Pulmonary Arterial Load in Patients With Pulmonary Hypertension
por: Ryo Inuzuka, et al.
Publicado: (2018)

Incremental Experience in In Vitro Primary Culture of Human Pulmonary Arterial Endothelial Cells Harvested from <i>Swan-Ganz</i> Pulmonary Arterial Catheters
por: Birger Tielemans, et al.
Publicado: (2021)

A syndrome of severe idiopathic pulmonary parenchymal disease with pulmonary hypertension in Pekingese
por: Köster LS, et al.
Publicado: (2016)